ProShares UltraShort Health Care (RXD) Covered Calls

ProShares UltraShort Health Care ETF seeks daily investment results that correspond to twice the inverse (-2x) of the daily performance of the Dow Jones U.S. Health Care Index. The fund offers a way for investors to profit from or hedge against declines in large-cap U.S. healthcare stocks, including pharmaceutical, biotechnology, and medical device companies. It utilizes derivative instruments to amplify inverse returns and is designed for short-term tactical use by sophisticated traders.

You can sell covered calls on ProShares UltraShort Health Care to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for RXD (prices last updated Mon 4:16 PM ET):

Want to make money with covered calls?  Sign Up For A Free Trial

The ProShares UltraShort Health Care ETF (RXD) is a leveraged inverse financial tool designed to provide magnified bearish exposure to the U.S. healthcare sector. The fund seeks to deliver daily investment results, before fees and expenses, that correspond to twice the inverse (-2x) of the daily performance of the Dow Jones U.S. Health Care Index. This benchmark includes major domestic companies involved in healthcare services, medical equipment manufacturing, and the development of pharmaceuticals and biotechnology products.

To achieve its -200% daily target, the fund primarily invests in financial derivatives, including swap agreements and futures contracts. These instruments allow the fund to gain leveraged short exposure without the need to physically short individual stocks. Because the fund resets its leverage on a daily basis, it is subject to the effects of mathematical compounding. This means that over periods longer than one day, the fund’s performance may deviate significantly from the simple inverse of the index return, making it a specialized vehicle for tactical traders rather than long-term investors.

Competitive Landscape

RXD operates within a specialized niche of leveraged and inverse sector ETFs. It is frequently used by traders to express high-conviction bearish views or to hedge existing healthcare portfolios. Key peers and alternatives include:

1. Direxion Daily S&P Biotech Bear 3X Shares: This fund offers even more aggressive inverse exposure (-3x) but focuses specifically on the more volatile biotechnology sub-sector.
2. Health Care Select Sector SPDR Fund: While this is a long-only fund, it is the primary benchmark for the sector and is often the core holding that traders use RXD to hedge against.
3. UnitedHealth Group Incorporated: As a massive constituent of the underlying index, this individual stock often drives the performance that RXD seeks to invert.
4. Vanguard Health Care ETF: A broad-market long competitor that provides 1x exposure to a similar basket of healthcare equities, serving as a primary target for bearish tactical shifts.

Strategic Outlook and Innovation

The strategic focus of the fund is to provide high-fidelity, magnified inverse correlation for participants navigating healthcare market cycles. Management prioritizes precise daily rebalancing and the maintenance of deep liquidity, which are essential for traders reacting to sudden regulatory shifts or clinical trial results that impact the sector. By managing a diverse pool of derivative counterparties, the fund aims to minimize tracking error and ensure that its leveraged short mechanism remains effective during various market regimes.

Innovation for the fund centers on optimizing the execution of its daily swap resets to reduce the internal "cost of carry" associated with leveraged short positions. As the healthcare industry evolves with the integration of digital health and personalized medicine, the underlying index is updated to reflect these trends, ensuring RXD remains a modern tool for betting against the sector. Future growth is driven by the increasing volatility in healthcare policy and the demand for sophisticated hedging instruments that allow investors to manage "tail risk" without liquidating their core long-term equity positions.

Want more examples? RWX Covered Calls | RXI Covered Calls